ANUHPHR
Anuh Pharma Limited
Each stock's 10,000-path forecast, rendered as light.
Anuh Pharma Limited (ANUHPHR) Stock Analysis & Case Study
Is ANUHPHR a good buy? The data-driven verdict.
on the numbers it tread carefully, a Downstox Snapshot Score of 44/100.
On the numbers, Anuh Pharma Limited (ANUHPHR) tread carefully, a Downstox Snapshot Score of 44/100, weighing a 22% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
ANUHPHR share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 1.5y of ANUHPHR history (-22%/yr drift, 38%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| ANUHPHR 2027 | ₹36 | ₹59 | ₹96 | -26% |
| ANUHPHR 2028 | ₹22 | ₹44 | ₹88 | -45% |
| ANUHPHR 2029 | ₹14 | ₹33 | ₹76 | -58% |
| ANUHPHR 2030 | ₹9 | ₹24 | ₹64 | -69% |
| ANUHPHR 2031 | ₹6 | ₹18 | ₹54 | -77% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability ANUHPHR goes up, or doubles?
The bull case for ANUHPHR
- Anuh Pharma Limited is part of the NSE universe with live, tracked fundamentals on Downstox.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹76.
The bear case & risks
- The probability model is cautious 12 months out, only a 22% chance of finishing above today's price.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹14.
ANUHPHR volatility & expected range, how bumpy is the ride?
Over the last 1.5 years ANUHPHR compounded at -22%/year with annualized volatility of 38%. That volatility implies a 1-year 80% range of ₹36-₹96, the honest backbone behind any single price target.
ANUHPHR price forecast, the full 60-month probability fan
ANUHPHR price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds ANUHPHR hits common targets within the simulated horizon?
Full multi-horizon detail on the ANUHPHR price target & forecast page.
ANUHPHR vs peers,sector comparison
About Anuh Pharma Limited: sector, index & market-cap context
Anuh Pharma Limited (ANUHPHR) is an NSE-listed company.
How the ANUHPHR Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Anuh Pharma Limited's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
ANUHPHR analysis, FAQs
Is Anuh Pharma Limited (ANUHPHR) a good buy?
On the numbers, Anuh Pharma Limited (ANUHPHR) tread carefully, a Downstox Snapshot Score of 44/100, weighing a 22% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is ANUHPHR overvalued or undervalued?
Valuation ratios for ANUHPHR are tracked live on Downstox.
What is the ANUHPHR share price target for 2031?
ANUHPHR's probability-weighted 2031 median target is ₹18, with an 80% range of ₹6-₹54 (10,000-path Monte-Carlo).
What is the probability ANUHPHR doubles in 5 years?
The modelled probability of ANUHPHR reaching ₹160 (2×) within 5 years is 0%.
What is the bull case for ANUHPHR?
Anuh Pharma Limited is part of the NSE universe with live, tracked fundamentals on Downstox.
What are the risks in ANUHPHR?
The probability model is cautious 12 months out, only a 22% chance of finishing above today's price.